Institutional investors purchased a net $19.0 million shares of AZN during the quarter ended June 2014 and now own 8.22% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN MUTUAL ADVISERS LLC Bought 3.5 Million shares of AstraZeneca PLC
MASON CAPITAL MANAGEMENT LLC Bought 3.3 Million shares of AstraZeneca PLC
JANE STREET CAPITAL LLC Bought 1.8 Million shares of AstraZeneca PLC